25 XP   0   0   10

Guangdong Hybribio Biotech Co Ltd
Buy, Hold or Sell?

Let's analyse Hybribio together

PenkeI guess you are interested in Guangdong Hybribio Biotech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangdong Hybribio Biotech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangdong Hybribio Biotech Co Ltd

I send you an email if I find something interesting about Guangdong Hybribio Biotech Co Ltd.

Quick analysis of Hybribio (30 sec.)










What can you expect buying and holding a share of Hybribio? (30 sec.)

How much money do you get?

How much money do you get?
¥0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥8.08
Expected worth in 1 year
¥18.92
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥11.55
Return On Investment
184.7%

For what price can you sell your share?

Current Price per Share
¥6.25
Expected price per share
¥5.65 - ¥7.81
How sure are you?
50%

1. Valuation of Hybribio (5 min.)




Live pricePrice per Share (EOD)

¥6.25

Intrinsic Value Per Share

¥5.16 - ¥14.92

Total Value Per Share

¥13.24 - ¥23.00

2. Growth of Hybribio (5 min.)




Is Hybribio growing?

Current yearPrevious yearGrowGrow %
How rich?$722.3m$480.2m$242.1m33.5%

How much money is Hybribio making?

Current yearPrevious yearGrowGrow %
Making money$238.4m$117.7m$120.6m50.6%
Net Profit Margin30.8%31.9%--

How much money comes from the company's main activities?

3. Financial Health of Hybribio (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#39 / 146

Most Revenue
#25 / 146

Most Profit
#13 / 146

What can you expect buying and holding a share of Hybribio? (5 min.)

Welcome investor! Hybribio's management wants to use your money to grow the business. In return you get a share of Hybribio.

What can you expect buying and holding a share of Hybribio?

First you should know what it really means to hold a share of Hybribio. And how you can make/lose money.

Speculation

The Price per Share of Hybribio is ¥6.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hybribio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hybribio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥8.08. Based on the TTM, the Book Value Change Per Share is ¥2.71 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hybribio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.375.9%0.375.9%0.182.9%0.142.2%0.101.6%
Usd Book Value Change Per Share0.376.0%0.376.0%0.203.2%0.182.9%0.162.6%
Usd Dividend Per Share0.020.4%0.020.4%0.020.3%0.010.2%0.010.2%
Usd Total Gains Per Share0.406.4%0.406.4%0.223.5%0.203.1%0.172.7%
Usd Price Per Share2.33-2.33-4.08-3.40-4.00-
Price to Earnings Ratio6.31-6.31-22.39-57.24-119.75-
Price-to-Total Gains Ratio5.84-5.84-18.76-41.92-51.60-
Price to Book Ratio2.08-2.08-5.49-7.86-13.18-
Price-to-Total Gains Ratio5.84-5.84-18.76-41.92-51.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.86375
Number of shares1157
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.370.18
Usd Total Gains Per Share0.400.20
Gains per Quarter (1157 shares)461.55226.55
Gains per Year (1157 shares)1,846.21906.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11131733183664842896
22263466368212816841802
33395199552819225262708
44526933737425633683614
55658666922032042104520
6678103991106638550535426
7791121321291244958956332
8905138651475851367377238
91018155981660457775798144
101131173311845064184219050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Hybribio

About Guangdong Hybribio Biotech Co Ltd

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. The company was founded in 2003 and is based in Chaozhou, China.

Fundamental data was last updated by Penke on 2024-04-01 19:25:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Guangdong Hybribio Biotech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hybribio earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hybribio to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 30.8% means that ¥0.31 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 30.8%. The company is making a huge profit. +2
  • The TTM is 30.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ30.8%TTM30.8%0.0%
TTM30.8%YOY31.9%-1.1%
TTM30.8%5Y25.9%+5.0%
5Y25.9%10Y24.0%+1.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ30.8%-7.2%+38.0%
TTM30.8%-6.3%+37.1%
YOY31.9%1.3%+30.6%
5Y25.9%-2.2%+28.1%
10Y24.0%-1.4%+25.4%
1.1.2. Return on Assets

Shows how efficient Hybribio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hybribio to the Diagnostics & Research industry mean.
  • 25.6% Return on Assets means that Hybribio generated ¥0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 25.6%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 25.6%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.6%TTM25.6%0.0%
TTM25.6%YOY20.1%+5.5%
TTM25.6%5Y15.9%+9.7%
5Y15.9%10Y14.5%+1.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ25.6%-1.5%+27.1%
TTM25.6%-1.2%+26.8%
YOY20.1%-0.6%+20.7%
5Y15.9%-0.6%+16.5%
10Y14.5%-0.9%+15.4%
1.1.3. Return on Equity

Shows how efficient Hybribio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hybribio to the Diagnostics & Research industry mean.
  • 35.2% Return on Equity means Hybribio generated ¥0.35 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 35.2%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 35.2%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ35.2%TTM35.2%0.0%
TTM35.2%YOY26.7%+8.5%
TTM35.2%5Y20.5%+14.7%
5Y20.5%10Y18.2%+2.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ35.2%-0.5%+35.7%
TTM35.2%-+35.2%
YOY26.7%0.3%+26.4%
5Y20.5%-1.5%+22.0%
10Y18.2%-2.5%+20.7%

1.2. Operating Efficiency of Guangdong Hybribio Biotech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hybribio is operating .

  • Measures how much profit Hybribio makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hybribio to the Diagnostics & Research industry mean.
  • An Operating Margin of 43.2% means the company generated ¥0.43  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 43.2%. The company is operating very efficient. +2
  • The TTM is 43.2%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ43.2%TTM43.2%0.0%
TTM43.2%YOY39.1%+4.1%
TTM43.2%5Y30.6%+12.6%
5Y30.6%10Y28.8%+1.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ43.2%-6.2%+49.4%
TTM43.2%-5.8%+49.0%
YOY39.1%4.8%+34.3%
5Y30.6%1.6%+29.0%
10Y28.8%-2.0%+30.8%
1.2.2. Operating Ratio

Measures how efficient Hybribio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.81 means that the operating costs are ¥0.81 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 0.811. The company is less efficient in keeping operating costs low.
  • The TTM is 0.811. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.811TTM0.8110.000
TTM0.811YOY0.910-0.099
TTM0.8115Y0.917-0.107
5Y0.91710Y0.924-0.006
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8111.310-0.499
TTM0.8111.303-0.492
YOY0.9101.240-0.330
5Y0.9171.270-0.353
10Y0.9241.228-0.304

1.3. Liquidity of Guangdong Hybribio Biotech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hybribio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 3.23 means the company has ¥3.23 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 3.229. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.229. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.229TTM3.2290.000
TTM3.229YOY3.767-0.538
TTM3.2295Y5.417-2.188
5Y5.41710Y5.634-0.217
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2292.194+1.035
TTM3.2292.366+0.863
YOY3.7672.753+1.014
5Y5.4172.989+2.428
10Y5.6343.000+2.634
1.3.2. Quick Ratio

Measures if Hybribio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hybribio to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.28 means the company can pay off ¥2.28 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 2.281. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.281. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.281TTM2.2810.000
TTM2.281YOY2.668-0.387
TTM2.2815Y3.157-0.876
5Y3.15710Y2.980+0.178
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2811.273+1.008
TTM2.2811.355+0.926
YOY2.6681.563+1.105
5Y3.1571.952+1.205
10Y2.9802.127+0.853

1.4. Solvency of Guangdong Hybribio Biotech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hybribio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hybribio to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.22 means that Hybribio assets are financed with 22.3% credit (debt) and the remaining percentage (100% - 22.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 0.223. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.223. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.223TTM0.2230.000
TTM0.223YOY0.179+0.045
TTM0.2235Y0.139+0.085
5Y0.13910Y0.131+0.007
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2230.425-0.202
TTM0.2230.411-0.188
YOY0.1790.393-0.214
5Y0.1390.450-0.311
10Y0.1310.448-0.317
1.4.2. Debt to Equity Ratio

Measures if Hybribio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hybribio to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 30.7% means that company has ¥0.31 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The MRQ is 0.307. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.307. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.3070.000
TTM0.307YOY0.237+0.070
TTM0.3075Y0.179+0.128
5Y0.17910Y0.165+0.014
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3070.606-0.299
TTM0.3070.571-0.264
YOY0.2370.606-0.369
5Y0.1790.637-0.458
10Y0.1650.730-0.565

2. Market Valuation of Guangdong Hybribio Biotech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hybribio generates.

  • Above 15 is considered overpriced but always compare Hybribio to the Diagnostics & Research industry mean.
  • A PE ratio of 6.31 means the investor is paying ¥6.31 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The EOD is 2.342. Based on the earnings, the company is cheap. +2
  • The MRQ is 6.313. Based on the earnings, the company is cheap. +2
  • The TTM is 6.313. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.342MRQ6.313-3.972
MRQ6.313TTM6.3130.000
TTM6.313YOY22.388-16.075
TTM6.3135Y57.244-50.930
5Y57.24410Y119.750-62.507
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.342-0.202+2.544
MRQ6.313-0.402+6.715
TTM6.313-0.119+6.432
YOY22.388-0.003+22.391
5Y57.2442.211+55.033
10Y119.7504.907+114.843
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The EOD is 7.029. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 18.950. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 18.950. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD7.029MRQ18.950-11.921
MRQ18.950TTM18.9500.000
TTM18.950YOY-1,960.686+1,979.636
TTM18.9505Y-254.830+273.780
5Y-254.83010Y421.848-676.678
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD7.029-0.179+7.208
MRQ18.950-0.417+19.367
TTM18.950-1.288+20.238
YOY-1,960.686-2.547-1,958.139
5Y-254.830-1.999-252.831
10Y421.848-2.372+424.220
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hybribio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.08 means the investor is paying ¥2.08 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangdong Hybribio Biotech Co Ltd:

  • The EOD is 0.773. Based on the equity, the company is cheap. +2
  • The MRQ is 2.084. Based on the equity, the company is underpriced. +1
  • The TTM is 2.084. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.773MRQ2.084-1.311
MRQ2.084TTM2.0840.000
TTM2.084YOY5.490-3.406
TTM2.0845Y7.858-5.774
5Y7.85810Y13.184-5.326
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.7731.877-1.104
MRQ2.0842.437-0.353
TTM2.0842.235-0.151
YOY5.4903.239+2.251
5Y7.8583.450+4.408
10Y13.1844.040+9.144
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangdong Hybribio Biotech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.7102.7100%1.455+86%1.317+106%1.155+135%
Book Value Per Share--8.0858.0850%5.375+50%4.177+94%3.309+144%
Current Ratio--3.2293.2290%3.767-14%5.417-40%5.634-43%
Debt To Asset Ratio--0.2230.2230%0.179+25%0.139+61%0.131+70%
Debt To Equity Ratio--0.3070.3070%0.237+29%0.179+71%0.165+86%
Dividend Per Share--0.1770.1770%0.118+50%0.100+76%0.082+116%
Eps--2.6692.6690%1.318+102%0.990+169%0.745+258%
Free Cash Flow Per Share--0.8890.8890%-0.015+102%0.137+551%0.097+814%
Free Cash Flow To Equity Per Share--0.5500.5500%-0.002+100%0.370+49%0.350+57%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--14.919--------
Intrinsic Value_10Y_min--5.160--------
Intrinsic Value_1Y_max--0.562--------
Intrinsic Value_1Y_min--0.235--------
Intrinsic Value_3Y_max--2.399--------
Intrinsic Value_3Y_min--0.954--------
Intrinsic Value_5Y_max--5.094--------
Intrinsic Value_5Y_min--1.941--------
Market Cap4040631200.000-170%10893541715.20010893541715.2000%19078244273.920-43%15912988347.108-32%18717136526.974-42%
Net Profit Margin--0.3080.3080%0.319-3%0.259+19%0.240+29%
Operating Margin--0.4320.4320%0.391+10%0.306+41%0.288+50%
Operating Ratio--0.8110.8110%0.910-11%0.917-12%0.924-12%
Pb Ratio0.773-170%2.0842.0840%5.490-62%7.858-73%13.184-84%
Pe Ratio2.342-170%6.3136.3130%22.388-72%57.244-89%119.750-95%
Price Per Share6.250-170%16.85016.8500%29.510-43%24.614-32%28.951-42%
Price To Free Cash Flow Ratio7.029-170%18.95018.9500%-1960.686+10447%-254.830+1445%421.848-96%
Price To Total Gains Ratio2.165-170%5.8375.8370%18.763-69%41.922-86%51.596-89%
Quick Ratio--2.2812.2810%2.668-15%3.157-28%2.980-23%
Return On Assets--0.2560.2560%0.201+27%0.159+61%0.145+77%
Return On Equity--0.3520.3520%0.267+32%0.205+72%0.182+93%
Total Gains Per Share--2.8872.8870%1.573+84%1.417+104%1.237+133%
Usd Book Value--722355383.856722355383.8560%480246759.848+50%373164973.605+94%295619052.496+144%
Usd Book Value Change Per Share--0.3740.3740%0.201+86%0.182+106%0.160+135%
Usd Book Value Per Share--1.1171.1170%0.743+50%0.577+94%0.457+144%
Usd Dividend Per Share--0.0240.0240%0.016+50%0.014+76%0.011+116%
Usd Eps--0.3690.3690%0.182+102%0.137+169%0.103+258%
Usd Free Cash Flow--79444270.63279444270.6320%-1344740.167+102%12204009.013+551%8687722.150+814%
Usd Free Cash Flow Per Share--0.1230.1230%-0.002+102%0.019+551%0.013+814%
Usd Free Cash Flow To Equity Per Share--0.0760.0760%0.000+100%0.051+49%0.048+57%
Usd Market Cap558415231.840-170%1505487465.0411505487465.0410%2636613358.656-43%2199174989.570-32%2586708268.028-42%
Usd Price Per Share0.864-170%2.3292.3290%4.078-43%3.402-32%4.001-42%
Usd Profit--238458463.785238458463.7850%117768527.899+102%88493665.337+169%66552317.418+258%
Usd Revenue--773501400.039773501400.0390%369411772.182+109%302222272.767+156%233195218.040+232%
Usd Total Gains Per Share--0.3990.3990%0.217+84%0.196+104%0.171+133%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+26 -910Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of Guangdong Hybribio Biotech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152.342
Price to Book Ratio (EOD)Between0-10.773
Net Profit Margin (MRQ)Greater than00.308
Operating Margin (MRQ)Greater than00.432
Quick Ratio (MRQ)Greater than12.281
Current Ratio (MRQ)Greater than13.229
Debt to Asset Ratio (MRQ)Less than10.223
Debt to Equity Ratio (MRQ)Less than10.307
Return on Equity (MRQ)Greater than0.150.352
Return on Assets (MRQ)Greater than0.050.256
Total10/10 (100.0%)

3.3. Technical Score

Let's check the technical score of Guangdong Hybribio Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.649
Ma 20Greater thanMa 506.987
Ma 50Greater thanMa 1007.088
Ma 100Greater thanMa 2008.109
OpenGreater thanClose6.430
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,731,126
Total Liabilities1,504,242
Total Stockholder Equity4,906,567
 As reported
Total Liabilities 1,504,242
Total Stockholder Equity+ 4,906,567
Total Assets = 6,731,126

Assets

Total Assets6,731,126
Total Current Assets4,400,278
Long-term Assets2,330,848
Total Current Assets
Cash And Cash Equivalents 1,024,776
Short-term Investments 387,057
Net Receivables 2,721,528
Inventory 118,739
Other Current Assets 93,148
Total Current Assets  (as reported)4,400,278
Total Current Assets  (calculated)4,345,247
+/- 55,030
Long-term Assets
Property Plant Equipment 1,316,959
Intangible Assets 218,767
Long-term Assets Other 54,892
Long-term Assets  (as reported)2,330,848
Long-term Assets  (calculated)1,590,618
+/- 740,230

Liabilities & Shareholders' Equity

Total Current Liabilities1,362,832
Long-term Liabilities141,410
Total Stockholder Equity4,906,567
Total Current Liabilities
Short Long Term Debt 98,484
Accounts payable 466,690
Other Current Liabilities 387,321
Total Current Liabilities  (as reported)1,362,832
Total Current Liabilities  (calculated)952,495
+/- 410,337
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt30,535
Long-term Liabilities  (as reported)141,410
Long-term Liabilities  (calculated)30,535
+/- 110,875
Total Stockholder Equity
Retained Earnings 3,200,518
Total Stockholder Equity (as reported)4,906,567
Total Stockholder Equity (calculated)3,200,518
+/- 1,706,049
Other
Capital Stock439,516
Common Stock Shares Outstanding 439,516
Net Invested Capital 5,005,052
Net Tangible Assets 4,721,359
Net Working Capital 3,037,446
Property Plant and Equipment Gross 1,316,959



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
579,152
1,069,642
1,188,259
1,296,968
2,856,964
4,231,385
6,731,126
6,731,1264,231,3852,856,9641,296,9681,188,2591,069,642579,152
   > Total Current Assets 
248,909
697,251
709,306
664,630
1,962,126
2,552,467
4,400,278
4,400,2782,552,4671,962,126664,630709,306697,251248,909
       Cash And Cash Equivalents 
51,413
185,760
62,797
257,333
390,958
521,973
1,024,776
1,024,776521,973390,958257,33362,797185,76051,413
       Short-term Investments 
0
0
0
5,000
860,000
677,144
387,057
387,057677,144860,0005,000000
       Net Receivables 
156,958
209,810
271,392
344,716
573,238
1,130,887
2,721,528
2,721,5281,130,887573,238344,716271,392209,810156,958
       Inventory 
34,766
32,506
40,203
43,414
96,305
147,143
118,739
118,739147,14396,30543,41440,20332,50634,766
       Other Current Assets 
3,393
903
4,703
9,601
16,425
51,947
93,148
93,14851,94716,4259,6014,7039033,393
   > Long-term Assets 
330,243
372,391
478,953
632,338
894,838
1,678,918
2,330,848
2,330,8481,678,918894,838632,338478,953372,391330,243
       Property Plant Equipment 
269,862
278,996
346,781
413,401
598,453
1,167,564
1,316,959
1,316,9591,167,564598,453413,401346,781278,996269,862
       Intangible Assets 
31,160
31,271
31,304
104,583
118,764
124,712
218,767
218,767124,712118,764104,58331,30431,27131,160
       Other Assets 
29,221
58,899
96,754
108,327
119,692
137,404
0
0137,404119,692108,32796,75458,89929,221
> Total Liabilities 
77,487
98,742
108,170
112,328
322,686
756,373
1,504,242
1,504,242756,373322,686112,328108,17098,74277,487
   > Total Current Liabilities 
60,624
84,518
96,432
106,217
303,022
677,586
1,362,832
1,362,832677,586303,022106,21796,43284,51860,624
       Short-term Debt 
10,000
0
0
0
0
0
0
00000010,000
       Short Long Term Debt 
10,000
0
0
0
75,272
151,500
98,484
98,484151,50075,27200010,000
       Accounts payable 
16,396
17,322
25,762
35,922
86,200
221,147
466,690
466,690221,14786,20035,92225,76217,32216,396
       Other Current Liabilities 
20,931
50,717
34,691
30,901
43,479
123,187
387,321
387,321123,18743,47930,90134,69150,71720,931
   > Long-term Liabilities 
16,862
14,224
11,738
6,111
19,664
78,786
141,410
141,41078,78619,6646,11111,73814,22416,862
       Capital Lease Obligations 
0
0
0
0
11,688
26,862
30,535
30,53526,86211,6880000
       Other Liabilities 
16,862
14,224
11,598
5,879
19,497
51,924
0
051,92419,4975,87911,59814,22416,862
> Total Stockholder Equity
489,489
960,600
967,449
1,081,718
2,390,534
3,194,385
4,906,567
4,906,5673,194,3852,390,5341,081,718967,449960,600489,489
   Common Stock
67,500
91,017
182,008
217,381
235,382
293,894
0
0293,894235,382217,381182,00891,01767,500
   Retained Earnings 
266,306
359,516
428,093
531,132
851,331
1,633,667
3,200,518
3,200,5181,633,667851,331531,132428,093359,516266,306
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
1,211
-33
-1,813
-1,885
-7,630
86,734
0
086,734-7,630-1,885-1,813-331,211



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,189,016
Cost of Revenue-690,621
Gross Profit1,498,3951,498,395
 
Operating Income (+$)
Gross Profit1,498,395
Operating Expense-1,434,050
Operating Income754,96664,345
 
Operating Expense (+$)
Research Development190,073
Selling General Administrative309,326
Selling And Marketing Expenses-
Operating Expense1,434,050499,399
 
Net Interest Income (+$)
Interest Income5,589
Interest Expense-7,952
Other Finance Cost-46,650
Net Interest Income44,287
 
Pretax Income (+$)
Operating Income754,966
Net Interest Income44,287
Other Non-Operating Income Expenses-
Income Before Tax (EBT)310,108754,966
EBIT - interestExpense = -7,952
409,393
417,345
Interest Expense7,952
Earnings Before Interest and Taxes (EBIT)-318,060
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax310,108
Tax Provision-2,994
Net Income From Continuing Ops307,114307,114
Net Income409,393
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--44,287
 

Technical Analysis of Hybribio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hybribio. The general trend of Hybribio is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hybribio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangdong Hybribio Biotech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.81 < 7.43 < 7.81.

The bearish price targets are: 5.65.

Tweet this
Guangdong Hybribio Biotech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangdong Hybribio Biotech Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangdong Hybribio Biotech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangdong Hybribio Biotech Co Ltd. The current macd is -0.25769753.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hybribio price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hybribio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hybribio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guangdong Hybribio Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangdong Hybribio Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangdong Hybribio Biotech Co Ltd. The current adx is 21.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hybribio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Guangdong Hybribio Biotech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangdong Hybribio Biotech Co Ltd. The current sar is 6.94848058.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangdong Hybribio Biotech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangdong Hybribio Biotech Co Ltd. The current rsi is 34.65. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Guangdong Hybribio Biotech Co Ltd Daily Relative Strength Index (RSI) ChartGuangdong Hybribio Biotech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangdong Hybribio Biotech Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hybribio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guangdong Hybribio Biotech Co Ltd Daily Stochastic Oscillator ChartGuangdong Hybribio Biotech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangdong Hybribio Biotech Co Ltd. The current cci is -161.1554542.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Guangdong Hybribio Biotech Co Ltd Daily Commodity Channel Index (CCI) ChartGuangdong Hybribio Biotech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangdong Hybribio Biotech Co Ltd. The current cmo is -35.26396861.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guangdong Hybribio Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangdong Hybribio Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangdong Hybribio Biotech Co Ltd. The current willr is -88.05970149.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Guangdong Hybribio Biotech Co Ltd Daily Williams %R ChartGuangdong Hybribio Biotech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangdong Hybribio Biotech Co Ltd.

Guangdong Hybribio Biotech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangdong Hybribio Biotech Co Ltd. The current atr is 0.27856798.

Guangdong Hybribio Biotech Co Ltd Daily Average True Range (ATR) ChartGuangdong Hybribio Biotech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangdong Hybribio Biotech Co Ltd. The current obv is 174,122,628.

Guangdong Hybribio Biotech Co Ltd Daily On-Balance Volume (OBV) ChartGuangdong Hybribio Biotech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangdong Hybribio Biotech Co Ltd. The current mfi is 34.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guangdong Hybribio Biotech Co Ltd Daily Money Flow Index (MFI) ChartGuangdong Hybribio Biotech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangdong Hybribio Biotech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Guangdong Hybribio Biotech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangdong Hybribio Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.649
Ma 20Greater thanMa 506.987
Ma 50Greater thanMa 1007.088
Ma 100Greater thanMa 2008.109
OpenGreater thanClose6.430
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hybribio with someone you think should read this too:
  • Are you bullish or bearish on Hybribio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hybribio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangdong Hybribio Biotech Co Ltd

I send you an email if I find something interesting about Guangdong Hybribio Biotech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangdong Hybribio Biotech Co Ltd.

Receive notifications about Guangdong Hybribio Biotech Co Ltd in your mailbox!